SEC Tracker
Get the app

Guardant Health GH

Medina Manuel Hidalgo (Director) plans to sell 1,250 GH shares, about $131,250

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Dec 8, 2025
  2. Broker: Charles Schwab & Co., Inc.
  3. Shares acquired by: Restricted Stock Lapse; Stock Option Exercise

All of Medina Manuel Hidalgo's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 1,000 shares at $105 on Dec 8, 2025 · Form 4
  • Sold 250 shares at $105 on Dec 8, 2025 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Guardant Health files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. Lumexa Imaging Holdings LMRI
  2. RadNet RDNT public float $4.1B, Jun 30, 2025
  3. Caris Life Sciences CAI public float $3.9B, Jun 30, 2025
  4. Exact Sciences EXAS public float $10.0B, Jun 30, 2025
  5. BillionToOne BLLN

Data on this page was fetched . The filing on SEC.gov is the record.